 |
|
Use of Parathyroid Hormone and Rehabilitation Reduces Subsequent Vertebral Body Fractures after Balloon Kyphoplasty
Masaki Ueno, Emi Toriumi, Aki Yoshii, Yuki Tabata, Takeshi Furudate, Yusuke Tajima
Asian Spine J. 2022;16(3):432-439. Published online 2021 Jun 17 DOI: https://doi.org/10.31616/asj.2020.0608
|
|
Citations to this article as recorded by
 Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty
Masaki Ueno, Yusuke Tajima, Shogo Ito, Masaki Tsuji, Emi Toriumi, Aki Yoshii, Nanaka Otake, Hisashi Tanaka
Archives of Osteoporosis.2024;[Epub] CrossRef Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health
Paul J. Kostenuik, Neil Binkley, Paul A. Anderson
Current Osteoporosis Reports.2023; 21(4): 386. CrossRef Adjacent Fracture Rates Following Balloon Kyphoplasty in Osteoporotic Vertebral Compression Fractures: A Case Series
Hannah Goldman-Daleo, Benjamin Rachman, Rahul Mhaskar
Cureus.2023;[Epub] CrossRef Application of Escherichia coli-Derived Recombinant Human Bone Morphogenic Protein-2 to Unstable Spinal Fractures
Young-Hoon Kim, Jun-Seok Lee, Kee-Yong Ha, Sang-Il Kim, Ho-Young Jung, Geon-U Kim, Yongwon Joh, Hyung-Youl Park
Bioengineering.2023; 10(10): 1114. CrossRef Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk
Jae-Won Shin, Quen He, Yong June Suk, Sang-Ho Kim, Hak-Sun Kim
Osteoporosis International.2022; 33(11): 2409. CrossRef
|